Cara Therapeutics | CARA - Ingresos Por Ventas





Ventas Cambio Fecha
Acadia Pharmaceuticals USD 307.96M 39.9M 2026-06
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Chugai Pharma JPY 341.6B 19.85B 2026-06
Cipla INR 71.19B 5.78B 2026-06
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 6.35M 60.98M 2026-03
CSL USD 8.33B 4.79B 2025-12
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 481M 104M 2026-06
J&J USD 25.31B 1.21B 2026-06
Neurocrine Biosciences USD 959M 148M 2026-06
Pacira USD 192.4M 15.4M 2026-06
Pfizer USD 15.03B 530M 2026-06
RedHill Biopharma USD 1.29M 722K 2024-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12